Press Releases

Cabozantanib has been recommended by NICE as an option for treating advanced hepatocellular carcinoma (HCC),…

Dublin, Ireland, 25th/26th September 2022 Tánaiste joins Ipsen Ireland to launch upgraded manufacturing site in…

Ireland, May 2022 Blanchardstown-based, biopharmaceutical Ipsen has been announced overall Pharma Industry Company of the…

SLOUGH, UK, 21 March 2022 — Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment…

WREXHAM, UK, 24 February 2022 Today, Simon Hart MP, Secretary of State for Wales, visited…

Advanced kidney cancer patients in Scotland become amongst the first in world to access CABOMETYX®▼…

In partnership with New Scientist, Ipsen UK has surveyed almost 800 young people to understand…

 Prostate cancer is the most diagnosed cancer in the UK, with 57,192 men diagnosed in…

Initially focusing on two rare conditions, MendelScan technology will integrate with patient records to aid…